What is Haemonetics's gross profit?

Haemonetics (HAE) reported gross profit of $198.21M in Q1 2026.

How has Haemonetics's gross profit changed year-over-year?

Haemonetics's gross profit increased by 2.7% year-over-year, from $193.05M to $198.21M.

What is the long-term trend for Haemonetics's gross profit?

Over 4 years (2022 to 2026), Haemonetics's gross profit has grown at a 11.7% compound annual growth rate (CAGR), from $505.5M to $787.59M.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Haemonetics HAE Gross Profit

Gross Profit at other companies

AbbottABT

$6.27B+6.5%

TFX

TeleflexTFX

$307.43M+20.4%

Boston ScientificBSX

$3.61B+12.6%

MedtronicMDT

$6.41B+10.9%

LivaNovaLIVN

$243.75M+12.7%

ICU MedicalICUI

$206.23M-1.8%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

$346.4Mtotal revenue−$148.1Mtotal cost of revenue=$198.21M

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's gross profit?: Haemonetics (HAE) reported gross profit of $198.21M in Q1 2026.
How has Haemonetics's gross profit changed year-over-year?: Haemonetics's gross profit increased by 2.7% year-over-year, from $193.05M to $198.21M.
What is the long-term trend for Haemonetics's gross profit?: Over 4 years (2022 to 2026), Haemonetics's gross profit has grown at a 11.7% compound annual growth rate (CAGR), from $505.5M to $787.59M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.